Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial

Post time 2024-6-17 09:03:12

journal：International Journal of General Medicine

Authors：Francesco Di Pierro; Somia Iqtadar; Amjad Khan; Sami Ullah Mumtaz; Mohsin Masud Chaudhry; Alexander Bertuccioli; Giuseppe Derosa; Pamela Maffioli; Stefano Togni; Antonella Riva; Pietro Allegrini; Saeed Khan

Published date：--

DOI：10.2147/ijgm.s318949

PDF link：https://www.dovepress.com/getfile.php?fileID=70920

Article link：http://dx.doi.org/10.2147/ijgm.s318949

Article Source：Informa UK Limited。

Remark：

Post time 2024-6-17 09:03:13

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Other] Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Other] Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Other] Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial